CDLX icon

Cardlytics

3.40 USD
+0.24
7.59%
At close Jan 21, 4:00 PM EST
After hours
3.49
+0.09
2.65%
1 day
7.59%
5 days
13.71%
1 month
-11.92%
3 months
-16.67%
6 months
-61.67%
Year to date
-8.85%
1 year
-48.48%
5 years
-96.05%
10 years
-74.57%
 

About: Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Employees: 456

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

90% more call options, than puts

Call options by funds: $5M | Put options by funds: $2.64M

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

11.78% less ownership

Funds ownership: 73.75% [Q2] → 61.97% (-11.78%) [Q3]

13% less funds holding

Funds holding: 127 [Q2] → 111 (-16) [Q3]

38% less funds holding in top 10

Funds holding in top 10: 8 [Q2] → 5 (-3) [Q3]

47% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 30

68% less capital invested

Capital invested by funds: $306M [Q2] → $99.2M (-$207M) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for CDLX.

Financial journalist opinion

Based on 18 articles about CDLX published over the past 30 days

Neutral
Accesswire
7 hours ago
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
Neutral
Accesswire
1 day ago
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
Neutral
GlobeNewsWire
1 day ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLX
NEW YORK, Jan. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQ: CDLX) resulting from allegations that Cardlytics may have issued materially misleading business information to the investing public.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLX
Neutral
Accesswire
2 days ago
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
LOS ANGELES, CA / ACCESS Newswire / January 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
Neutral
Accesswire
3 days ago
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
LOS ANGELES, CA / ACCESS Newswire / January 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Cardlytics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out
Neutral
GlobeNewsWire
4 days ago
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLX
NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQ: CDLX) resulting from allegations that Cardlytics may have issued materially misleading business information to the investing public.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLX
Neutral
Accesswire
4 days ago
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
LOS ANGELES, CA / ACCESS Newswire / January 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Cardlytics, Inc. For Securities Law Violations
Neutral
PRNewsWire
4 days ago
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES , Jan. 17, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
Neutral
PRNewsWire
4 days ago
CDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQ: CDLX) resulting from allegations that Cardlytics may have issued materially misleading business information to the investing public. So What: If you purchased Cardlytics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
CDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Neutral
Business Wire
5 days ago
Securities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CARDLYTICS, INC. (CDLX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On August.
Securities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Charts implemented using Lightweight Charts™